Select Medical Hldgs: Q2 Earnings Insights

Select Medical Hldgs (NYSE:SEM) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Select Medical Hldgs (NYSE:SEM) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:30 PM.

Here’s what investors need to know about the announcement.

Earnings

Select Medical Hldgs missed estimated earnings by 21.82%, reporting an EPS of $0.43 versus an estimate of $0.55.

Revenue was up $21.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 3.59% increase in the share price the next day.

Here’s a look at Select Medical Hldgs’s past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.27 0.31 0.52
EPS Actual 0.37 0.37 0.57 1.22
Revenue Estimate 1.56B 1.52B 1.44B 1.44B
Revenue Actual 1.60B 1.56B 1.53B 1.56B

To track all earnings releases for Select Medical Hldgs visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Dole’s Q1 Bottom-Line Beats Street View, Thanks To Higher Banana, Pineapple Volumes

Dole PLC reported a 6.6% increase in Q1 FY24 sales to $2.12 billion, matching analyst estimates. The growth was driven by strong operations and favorable currency impacts. Gross profit rose 8.7% to $194.7 million, while operating income surged over 100% to $71.5 million. Adjusted EPS of $0.43 exceeded the $0.31 estimate. The company also declared a $0.08 per share dividend.

DOLE